Last updated on February 2018

Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children


Brief description of study

This study evaluates the use of carfilzomib in combination with cyclophosphamide and etoposide for children with relapsed/refractory solid tumors or leukemia. The medications cyclophosphamide and etoposide are standard drugs often used together for the treatment of cancer in children with solid tumors or leukemia.

Carfilzomib is FDA (Food and Drug Administration) approved in the United States for adults with multiple myeloma (a type of cancer). However, this drug is not approved for the disease being treated in this study. Since carfilzomib has not yet been used in this setting to treat this condition, the investigators must first find the best dose to give. The investigators are looking for the highest dose of carfilzomib that can be given safely. Therefore, not all children taking part in this study will receive the same dose of the study drug in the first part of the trial.

Detailed Study Description

The purpose of this study is to find out what effects, good and/or bad, treatment with a new combination of drugs, cyclophosphamide, etoposide, and carfilzomib has on cancer.

In part 1 of the trial, small groups of children will be enrolled in steps. The first group will be given a certain dose of carfilzomib. If these children do not have side effects which are too bad, the next small group of children enrolled will receive a higher dose. This increase in doses with groups of people will continue until we find the highest dose of the drug that can be given without causing severe or unmanageable side effects.

Part 2 of this study will enroll additional patients at the highest tolerable dose found in Part 1 in order to get more information on side effects and make sure the dose is tolerable.

Clinical Study Identifier: NCT02512926

Contact Investigators or Research Sites near you

Start Over

Jessica Boklan, MD

Phoenix Children's Hospital
Phoenix, AZ United States
  Connect »

Kathleen Neville, MD, MS

Arkansas Children's Hospital
Little Rock, AR United States
  Connect »

Norman Lacayo, MD

Stanford University School of Medicine and Stanford Cancer Institute
Palo Alto, CA United States
  Connect »

Steven DuBois, MD

Dana Farber Cancer Institute
Boston, MA United States
  Connect »

Tanya Trippett, MD

Memorial Sloan-Kettering Cancer Center
New York, NY United States
  Connect »

Valerie Brown, MD, PhD

Penn State Hershey Children's Hospital
Hershey, PA United States
  Connect »

Anne Franklin, MD

MD Anderson Cancer Center
Houston, TX United States
  Connect »

Anne-Marie Langevin, MD

University of Texas Health Science Center at San Antonio
San Antonio, TX United States
  Connect »

Aru Narendran, MD, PhD

Alberta Children's Hospital
Calgary, AB Canada
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.